RECRUITINGINTERVENTIONAL

Comparison of the Effects of Inspiratory Muscle Training and Baduanjin Exercises in Hypertrophic Cardiomyopathy Patients

Comparison of the Effects of Inspiratory Muscle Training and Baduanjin Exercises on Pulmonary Function, Exercise Capacity and Quality of Life in Patients With Hypertrophic Cardiomyopathy

About This Trial

The study aims to compare the effects of inspiratory muscle training and Baduanjin exercises on pulmonary function, exercise capacity, and quality of life in patients with hypertrophic cardiomyopathy. By investigating these interventions, the investigators seek to introduce novel approaches that can enhance pulmonary function, exercise capacity, and overall quality of life for these patients. In the study, which will involve three groups-the control group, the inspiratory muscle training (IMT) group, and the Baduanjin group-it was calculated that a total of 51 patients, with 17 in each group (n = 17), should be included. The IMT group will use an inspiratory muscle training device twice a day, every day of the week, for 15 minutes. This training will continue for 8 weeks, with supervision once a week and unsupervised sessions on the other days. The Baduanjin group will participate in a 50-minute exercise program, which includes a 10-minute warm-up, a 30-minute routine of eight separate movements, and a 10-minute cool-down. This will occur three times a week (twice in person and once online) for 8 weeks.

Who May Be Eligible (Plain English)

Who May Qualify: - Myocardial thickness in any region of the left ventricle is 15 mm or more on echocardiography or cardiac MRI - Clinically and hemodynamically stable (patients with NYHA Class I and II) - Patients over 18 years of age - Patients who provide willing to sign a consent form Who Should NOT Join This Trial: - Acute decompensated heart failure - Decreased ejection fraction (\<40%) - Unstable angina pectoris - Significant coronary artery disease (CAD) - Severe renal dysfunction (estimated glomerular filtration rate \<30 mL/min/m²) - Uncontrolled hypertension (despite medication) - Severe valve disease (moderate-severe aortic stenosis, advanced mitral regurgitation) - Severe neurological disorders causing autonomic dysfunction - Cognitive impairment that prevents communication - Recent fractures, osteoporosis, presence of tumors, pregnancy, or back and spine problems Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Myocardial thickness in any region of the left ventricle is 15 mm or more on echocardiography or cardiac MRI * Clinically and hemodynamically stable (patients with NYHA Class I and II) * Patients over 18 years of age * Patients who provide informed consent Exclusion Criteria: * Acute decompensated heart failure * Decreased ejection fraction (\<40%) * Unstable angina pectoris * Significant coronary artery disease (CAD) * Severe renal dysfunction (estimated glomerular filtration rate \<30 mL/min/m²) * Uncontrolled hypertension (despite medication) * Severe valve disease (moderate-severe aortic stenosis, advanced mitral regurgitation) * Severe neurological disorders causing autonomic dysfunction * Cognitive impairment that prevents communication * Recent fractures, osteoporosis, presence of tumors, pregnancy, or back and spine problems

Treatments Being Tested

OTHER

Inspiratory Muscle Training

The IMT group will use an inspiratory muscle training device twice a day, every day of the week, for 15 minutes. This training will continue for 8 weeks, with supervision once a week and unsupervised sessions on the other day

OTHER

Baduanjin Exercise

The Baduanjin group will participate in a 50-minute exercise program, which includes a 10-minute warm-up, a 30-minute routine of eight separate movements, and a 10-minute cool-down. This will occur three times a week (twice in person and once online) for 8 weeks.

Locations (1)

Istanbul University-Cerrahpasa (IUC) Cardiology Institute

Istanbul, Turkey (Türkiye)